Sight Diagnostics: A $71 Million Investment – CBI

Skip to content

About
Team
- Management
- Board of Directors
Portfolio
Investors
Contact Us

About
Team
- Management
- Board of Directors
Portfolio
Investors
Contact Us

Homepage / Press Release / Sight Diagnostics: A $71 Million Investment

Press Release

Sight Diagnostics: A $71 Million Investment

Home
About
Portfolio
Investors
Contact Us
Accessibility Statement
הצהרת נגישות

© 2021 Clal Biotechnology Industries Ltd. All rights reserved

Site by CadenSee - Let's Talk Medical